Literature DB >> 17459899

The role of atypical respiratory pathogens in exacerbations of chronic obstructive pulmonary disease.

B M W Diederen1, P D L P M van der Valk, J A W J Kluytmans, M F Peeters, R Hendrix.   

Abstract

The aetiology of acute exacerbations of chronic obstructive pulmonary disease (COPD) is heterogeneous and still under discussion. Serological studies have suggested that Mycoplasma pneumoniae, Chlamydia pneumoniae and Legionella pneumophila may play a role in acute exacerbations of COPD. The presence of these atypical pathogens in sputum samples was investigated in patients with stable COPD and with acute exacerbations of COPD using real-time PCR. The present study was part of a randomised, double-blind, single-centre study and a total of 248 sputum samples from 104 COPD patients were included. In total, 122 samples obtained during stable disease (stable-state sputa) and 126 samples obtained during acute exacerbations of COPD (exacerbation sputa) were tested. Of the 122 stable-state sputa, all samples were negative for M. pneumoniae and C. pneumoniae DNA, whereas one sample was positive for Legionella non-pneumophila DNA. Of the 126 exacerbation sputa, all samples were negative for M. pneumoniae and C. pneumoniae DNA, whereas one sample was positive for Legionella non-pneumophila DNA. The possible relationship between the presence of atypical pathogens and the aetiology of acute exacerbations in chronic obstructive pulmonary disease was investigated in patients with stable disease and in those with acute exacerbations using real-time PCR. No indication was found of a role for Legionella spp., Chlamydia pneumoniae or Mycoplasma pneumoniae in stable, moderately severe chronic obstructive pulmonary disease and in its exacerbations.

Entities:  

Mesh:

Year:  2007        PMID: 17459899     DOI: 10.1183/09031936.00012707

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  14 in total

1.  Guidelines for the management of adult lower respiratory tract infections--full version.

Authors:  M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij
Journal:  Clin Microbiol Infect       Date:  2011-11       Impact factor: 8.067

2.  Relation between chronic obstructive pulmonary disease and antibiotics.

Authors:  Salvador Sialer; Liapikou Adamantia; Mónica Guerrero; Antoni Torres
Journal:  Curr Infect Dis Rep       Date:  2012-06       Impact factor: 3.725

3.  In vivo function of airway epithelial TLR2 in host defense against bacterial infection.

Authors:  Qun Wu; Di Jiang; Maisha N Minor; Richard J Martin; Hong Wei Chu
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-01-14       Impact factor: 5.464

4.  Relationship Among Chlamydia and Mycoplasma Pneumoniae Seropositivity, IKZF1 Genotype and Chronic Obstructive Pulmonary Disease in A General Japanese Population: The Nagahama Study.

Authors:  Shigeo Muro; Yasuharu Tabara; Hisako Matsumoto; Kazuya Setoh; Takahisa Kawaguchi; Meiko Takahashi; Isao Ito; Yutaka Ito; Kimihiko Murase; Chikashi Terao; Shinji Kosugi; Ryo Yamada; Akihiro Sekine; Takeo Nakayama; Kazuo Chin; Michiaki Mishima; Fumihiko Matsuda
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

5.  Microorganisms Causing Community-Acquired Acute Bronchitis: The Role of Bacterial Infection.

Authors:  Ji Young Park; Sunghoon Park; Sun Hwa Lee; Myung Goo Lee; Yong Bum Park; Kil Chan Oh; Jae-Myung Lee; Do Il Kim; Ki-Hyun Seo; Kyeong-Cheol Shin; Kwang Ha Yoo; Yongchun Ko; Seung Hun Jang; Ki-Suck Jung; Yong Il Hwang
Journal:  PLoS One       Date:  2016-10-27       Impact factor: 3.240

6.  Use of serology and polymerase chain reaction to detect atypical respiratory pathogens during acute exacerbation of chronic obstructive pulmonary disease.

Authors:  Chi Young Jung; Yeoung Hun Choe; Sang Yeub Lee; Woo Jin Kim; Jong Deog Lee; Seung Won Ra; Eu Gene Choi; Jae Seung Lee; Myung Jae Park; Ju Ock Na
Journal:  Korean J Intern Med       Date:  2018-06-25       Impact factor: 2.884

7.  Assessment of some inflammatory biomarkers as predictors of outcome of acute respiratory failure on top of chronic obstructive pulmonary disease and evaluation of the role of bacteria.

Authors:  Hanaa Ahmed Shafiek; Nashwa Hassan Abd-Elwahab; Manal Mohammad Baddour; Mohamed Mabrouk El-Hoffy; Akram Abd-Elmoneim Degady; Yehia Mohamed Khalil
Journal:  ISRN Microbiol       Date:  2012-06-21

8.  Bacterial profile, antibiotic sensitivity and resistance of lower respiratory tract infections in upper egypt.

Authors:  Gamal Agmy; Sherif Mohamed; Yaser Gad; Esam Farghally; Hamdy Mohammedin; Hebba Rashed
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-09-02       Impact factor: 2.576

9.  Analysis of the airway microbiota of healthy individuals and patients with chronic obstructive pulmonary disease by T-RFLP and clone sequencing.

Authors:  Tetyana Zakharkina; Elke Heinzel; Rembert A Koczulla; Timm Greulich; Katharina Rentz; Josch K Pauling; Jan Baumbach; Mathias Herrmann; Christiane Grünewald; Hendrik Dienemann; Lutz von Müller; Robert Bals
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

10.  Prevalence of Mycoplasma Pneumoniae Infection in Patients with COPD Exacerbation; a Letter to the Editor.

Authors:  Ali Reza Amiri; Kiarash Ghazvini; Hamid Zamani Moghadam
Journal:  Emerg (Tehran)       Date:  2018-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.